Medivision Pharmaceuticals

Medivision Pharmaceuticals is an Egyptian specialty pharmaceutical company primarily focused on the ophthalmic therapeutic area. Founded in 2011, the company develops, manufactures, and markets a comprehensive range of eye care products, including treatments for glaucoma, ocular infections, and dry eye syndrome. Their portfolio features branded generic medications such as Latanovision, Moxivision, and Gativision, catering to various clinical needs in ophthalmology. With its headquarters in Giza, Egypt, Medivision Pharm serves the Middle East and North Africa (MENA) region through a robust distribution network and localized manufacturing capabilities. The company is committed to improving ocular health by providing high-quality, affordable medications and nutritional supplements.